A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy

NCT02798952 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: Engerix-B Kinder

Sponsor

GlaxoSmithKline